Completed PHASE1 INTERVENTIONAL 2-arm NCT01661894

Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly (3ECog)

Sponsor: Agency for Science, Technology and Research

Conditions Age-Related Cognitive Decline Alzheimer's Disease Dementia Mild Cognitive Impairment

Interventions BrainPalTM

Updated 6 times since 2017 Last updated: Jul 24, 2014 Started: Apr 30, 2012 Primary completion: Apr 30, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01661894, this PHASE1 trial focuses on Age-Related Cognitive Decline and Alzheimer's Disease and remains completed. Sponsored by Agency for Science, Technology and Research, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Mar 2023 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — Mar 2023 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Agency for Science, Technology and Research
Duke-NUS Graduate Medical School
National University of Singapore
Singapore Clinical Research Institute
Singapore General Hospital

Data source: Duke-NUS Graduate Medical School

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Singapore, Singapore